Rechercher | All Crowdz

Jessica Pineda Ajouter une nouvelle offre d'emploi Health
2026-05-18 14:26:28 -

Blood Cancer Drugs Market Industry Analysis and Opportunity Assessment
The blood cancer drugs market continues to evolve rapidly as advancements in oncology research, targeted therapies, and immunotherapy reshape treatment approaches worldwide. Blood cancers—including leukemia, lymphoma, and myeloma—remain among the most diagnosed and complex cancer types, requiring continuous innovation in drug development. Pharmaceutical companies are increasingly...

0 Commentaires 0 Parts 230 Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!
Shikha Sharma Ajouter une nouvelle offre d'emploi Autre
2026-06-09 12:12:57 -

Anti-Emetic Drugs Market Size, Share and Trends Forecast to 2030
According to the latest report published by Data Bridge Market Research, the Anti-Emetic Drugs Market Data Bridge Market Research analyses that the global anti-emetic drugs market which was USD 7,543.13 million in 2022, is expected to reach USD 12,840.23 million by 2030, and is expected to undergo a CAGR of 6.06% during the forecast period of 2023 to 2030 Global market research...

0 Commentaires 0 Parts 391 Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!
Sam Karan Ajouter une nouvelle offre d'emploi Health
2026-01-28 13:53:21 -

Cancer Drugs Market: Key Trends, Regional Insights, and Strategic Growth Opportunities by 2031
Cancer drugs also referred to as oncology or anticancer drugs are pharmaceutical products developed to treat cancer by eliminating cancer cells, inhibiting tumor growth, or activating the body’s immune system to combat malignant cells. These therapies include a broad spectrum of treatment options such as conventional chemotherapy, targeted therapy, immunotherapy, and hormone therapy....

0 Commentaires 0 Parts 773 Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!
Ksh Dbmr Ajouter une nouvelle offre d'emploi Networking
2026-03-16 06:27:38 -

How Are Targeted Cancer Therapies Driving Innovation in the Hormone-Refractory Oncology Drug Market?
Demand Outlook for Executive Summary Hormone-Refractory Oncology Drug Market Market Size and Share CAGR Value The global hormone-refractory oncology drug market size was valued at USD 5.33 billion in 2025 and is expected to reach USD 12.46 billion by 2033, at a CAGR of 11.20% during the forecast period The wide-ranging report deals with the new business challenges and investment...

0 Commentaires 0 Parts 750 Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!